Synopsys, Inc. · Technology
The price already needs more growth than analysts forecast, at both a 9% and an 8% discount rate.
At 24.0% margin the price requires 21.1% 3y revenue CAGR vs consensus 14.6%, a cushion of -19.8pt (-15.8pt at 1pt lower r) against a 4pt correction cut. The price already demands more growth than consensus, before any correction. A real but lagged customer channel.
Would recover if: Margin proves durably above 24% or consensus growth rises toward 21%, turning the cushion positive.. We re-check this against analyst estimates every evening.
10 years, at a 24% margin (analysts' margin, cut for cash conversion)
+9.7%/yr over 10 years once faded to terminal growth
points off 3-year analyst growth
13 published targets, set before the drop
Linked to AMD, AMZN, MSFT, NVDA, TSM
Does the profit analysts build their margin on actually arrive as cash? Measured over the last 3 annual statements filed before this test. After stock-based pay, 51% of reported profit arrived as operating cash, so the test cuts the analysts' 32% margin to 16%. That leaves a cushion of −29pt instead of −13pt, and the smaller of the two decides the group. Two or more red flags: this name cannot come out on top, however large its cushion.
How much of reported profit arrived as operating cash. Below 0.8× is a red flag.
Profit not backed by cash, as a share of assets, latest year. Above 10% is a red flag.
Staff paid in shares instead of cash, which flatters margins. Above 10% is a red flag.
Dilution of each share's claim on the business. Above 3% a year is a red flag.
Non-operating gains in the latest year. Above 25% is a red flag.
After capex. Shown for context: heavy investment is not bad earnings, so it is never solved under.
From the priced-in reconstruction of Sep 10, 2026. Its figures use that day's price and free-cash-flow margin, so they can differ from the stress test above.
The price at the price sits at the absolute floor of the published analyst range and is 29% below the median target, meaning the market has heard the bull case for AI-driven acceleration but actively refuses to pay for it.
Can Synopsys actually accelerate its top-line growth to a sustained 20%-plus rate using AI and integrated design tools, or is the recent 42% quarterly surge a temporary anomaly from the Ansys acquisition? The wired data can track segment revenue history to see if this acceleration persists quarter after quarter, but it cannot measure the pricing power or adoption rate of the new AI agent tools themselves.
What the price refuses to pay for, and the full reconstruction, on the SNPS quote page →A stress test of whether this narrative is still paid for by analyst forecasts, not a forecast that the stock will rise. The price-implied growth on its own has not predicted returns in our testing, and this list (sealed Nov 21, 2026) has not been graded yet. Cut sizes are assumptions. Not investment advice. Back to all names